Delivery Order SPE2DB20D9331-SPE2DB25FL1Z6
- Not listed
- The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 7, 2025, for the supply of Stelara 90 mg/mL syringes. The contract, which carries no set-aside designation, is scheduled for completion by August 28, 2025, with performance conducted at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in the System for Award...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Stelara 90 mg/ml syringes. The award, which carries no set-aside designation, is scheduled for completion by October 6, 2025, with fulfillment to occur at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor on this engagement. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 30, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the vendor to compete on an open basis despite its small...
- The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on August 29, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, represents a direct pharmaceutical supply fulfillment to support military healthcare operations. Performance is scheduled for completion by September 22, 2025, with...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 19, 2025, for the supply of Stelara 90 mg/mL syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of October 10, 2025. This delivery order carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's facility in Park Ridge, IL. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with an ultimate completion date of July 9, 2025. The award was made without a set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on a competitive basis leveraging its established...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a firm fixed-price contract structure and ultimate completion date of September 17, 2025. The contract carries no set-aside designation, allowing the vendor to compete directly...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Z6Delivery Order
The Defense Logistics Agency awarded a $32,499.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Stelara 90 mg/mL syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility, with an ultimate completion date of October 6, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal marketplace based on its established capabilities. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at approximately $500 million and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and specialty medications to support medical supply needs across Department of Defense healthcare facilities worldwide. As a consistent supplier of specialized pharmaceutical products to military health systems, DMS Pharmaceutical Group's delivery of Stelara—a biologic immunosuppressant—reflects the company's established role in the federal pharmaceutical supply chain for prescription medications and biologics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 9/15/25 |